Keith E Miller, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 620 Tenaha St, Center, TX 75935 Phone: 936-598-2716 |
News Archive
What do you think of when someone says, "hospital food" — green Jell-O anyone?
A new version of the human male is a distinct possibility, given the genetic erosion of the "junk" sex-determining chromosome that makes men male.
Known as "Your Doctor's Advice" (YDA), the program provides an easy-to-use, high-tech solution to a major contributing factor in patient noncompliance and poor medical outcomes.
Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that preclinical results presented at the AACR-IASLC (American Academy of Cancer Research – International Association for the Study of Lung Cancer) Joint Conference based on work done at Synta and at the Dana-Farber Cancer Institute in Boston showed that STA-9090, a potent, synthetic inhibitor of heat shock protein 90 (Hsp90), demonstrated potent activity against 100% of all non-small cell lung cancer cell lines tested, including those with EGFR, HER2 or KRAS mutations including the EGFR T790 mutation that is present in roughly 50% of cases of erlotinib or gefitinib resistance.
› Verified 4 days ago